Standard BioTools Inc. Common Stock
$0.73
$0.02 (+2.95%)
$0.72Day Range$0.75
Key Statistics
Market Cap
$286.58M
Shares Outstanding
392.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 10, 2011
Round Lot
100
Locale
US
Trading Data
Day Open
$0.72
Day High
$0.75
Day Low
$0.72
Volume
665.0K
VWAP
$0.73
Prev Close
$0.71
Transactions
--
Acc. Volume
--
About Standard BioTools Inc. Common Stock
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
PHARMACEUTICAL PREPARATIONSSIC 2834389 employees50 MILK STREET, BOSTON, MA, 02109(650) 266-6000IPO Feb 10, 2011US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001162194
- Composite FIGI
- BBG000S8WQB6
- Share Class FIGI
- BBG001T0FDP3
- Ticker Root
- LAB
- SIC Code
- 2834
About Standard BioTools Inc. Common Stock (LAB) Stock
Standard BioTools Inc. Common Stock (LAB) closed the 2026-09-17 session at $0.73, up 2.95% versus the previous close (+0.02). The stock opened at $0.72 and traded between $0.72 and $0.75 during that session. Session trading volume was 665K shares. The volume-weighted average price (VWAP) is $0.73.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.
Standard BioTools Inc. Common Stock has a market capitalization of $286.6 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. LAB is listed on the XNAS exchange. The company employs approximately 389 people. Standard BioTools Inc. Common Stock is headquartered in BOSTON, MA. The recorded listing date is 2011-02-10.
On this page you can find market LAB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.